Correction to: Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer (Investigational New Drugs, (2018), 10.1007/s10637-018-0663-0)

Laura W. Goff; Nilofer S. Azad; Stacey Stein; Jennifer G. Whisenant; Tatsuki Koyama; Ulka Vaishampayan; Howard Hochster; Roisin Connolly; Amy Weise; Patricia M. LoRusso; Safia N. Salaria; Wael El-Rifai; Jordan D. Berlin

doi:10.1007/s10637-018-0679-5

Correction to: Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer (Investigational New Drugs, (2018), 10.1007/s10637-018-0663-0)

Laura W. Goff, Nilofer S. Azad, Stacey Stein, Jennifer G. Whisenant, Tatsuki Koyama, Ulka Vaishampayan, Howard Hochster, Roisin Connolly, Amy Weise, Patricia M. LoRusso, Safia N. Salaria, Wael El-Rifai, Jordan D. Berlin

Research output: Contribution to journal › Comment/debate

Abstract

The authors would like to note that the investigator affiliations have been corrected to reflect the actual affiliations of each author. The authors would also like to note an amendment to the first name of the second author. Nilo Azad was changed to reflect the full name of the author, which is Nilofer S. Azad as shown above. The original article has been corrected.

Original language	English (US)
Number of pages	1
Journal	Investigational New Drugs
Volume	36
Issue number	6
DOIs	https://doi.org/10.1007/s10637-018-0679-5
State	Published - Dec 1 2018
Externally published	Yes

ASJC Scopus subject areas

Oncology
Pharmacology
Pharmacology (medical)

Access to Document

10.1007/s10637-018-0679-5

Fingerprint Dive into the research topics of 'Correction to: Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer (Investigational New Drugs, (2018), 10.1007/s10637-018-0663-0)'. Together they form a unique fingerprint.

Cite this

Goff, L. W., Azad, N. S., Stein, S., Whisenant, J. G., Koyama, T., Vaishampayan, U., Hochster, H., Connolly, R., Weise, A., LoRusso, P. M., Salaria, S. N., El-Rifai, W., & Berlin, J. D. (2018). Correction to: Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer (Investigational New Drugs, (2018), 10.1007/s10637-018-0663-0). Investigational New Drugs, 36(6). https://doi.org/10.1007/s10637-018-0679-5

Correction to : Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer (Investigational New Drugs, (2018), 10.1007/s10637-018-0663-0). / Goff, Laura W.; Azad, Nilofer S.; Stein, Stacey; Whisenant, Jennifer G.; Koyama, Tatsuki; Vaishampayan, Ulka; Hochster, Howard; Connolly, Roisin; Weise, Amy; LoRusso, Patricia M.; Salaria, Safia N.; El-Rifai, Wael; Berlin, Jordan D.

In: Investigational New Drugs, Vol. 36, No. 6, 01.12.2018.

Research output: Contribution to journal › Comment/debate

Goff, LW, Azad, NS, Stein, S, Whisenant, JG, Koyama, T, Vaishampayan, U, Hochster, H, Connolly, R, Weise, A, LoRusso, PM, Salaria, SN, El-Rifai, W & Berlin, JD 2018, 'Correction to: Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer (Investigational New Drugs, (2018), 10.1007/s10637-018-0663-0)', Investigational New Drugs, vol. 36, no. 6. https://doi.org/10.1007/s10637-018-0679-5

Goff, Laura W. ; Azad, Nilofer S. ; Stein, Stacey ; Whisenant, Jennifer G. ; Koyama, Tatsuki ; Vaishampayan, Ulka ; Hochster, Howard ; Connolly, Roisin ; Weise, Amy ; LoRusso, Patricia M. ; Salaria, Safia N. ; El-Rifai, Wael ; Berlin, Jordan D. / Correction to : Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer (Investigational New Drugs, (2018), 10.1007/s10637-018-0663-0). In: Investigational New Drugs. 2018 ; Vol. 36, No. 6.

@article{c9a1b42ad70c4a9286b5b881b13a08ae,

title = "Correction to: Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer (Investigational New Drugs, (2018), 10.1007/s10637-018-0663-0)",

abstract = "The authors would like to note that the investigator affiliations have been corrected to reflect the actual affiliations of each author. The authors would also like to note an amendment to the first name of the second author. Nilo Azad was changed to reflect the full name of the author, which is Nilofer S. Azad as shown above. The original article has been corrected.",

author = "Goff, {Laura W.} and Azad, {Nilofer S.} and Stacey Stein and Whisenant, {Jennifer G.} and Tatsuki Koyama and Ulka Vaishampayan and Howard Hochster and Roisin Connolly and Amy Weise and LoRusso, {Patricia M.} and Salaria, {Safia N.} and Wael El-Rifai and Berlin, {Jordan D.}",

year = "2018",

month = dec,

day = "1",

doi = "10.1007/s10637-018-0679-5",

language = "English (US)",

volume = "36",

journal = "Investigational New Drugs",

issn = "0167-6997",

publisher = "Kluwer Academic Publishers",

number = "6",

}

TY - JOUR

T1 - Correction to

T2 - Phase I study combining the aurora kinase a inhibitor alisertib with mFOLFOX in gastrointestinal cancer (Investigational New Drugs, (2018), 10.1007/s10637-018-0663-0)

AU - Goff, Laura W.

AU - Azad, Nilofer S.

AU - Stein, Stacey

AU - Whisenant, Jennifer G.

AU - Koyama, Tatsuki

AU - Vaishampayan, Ulka

AU - Hochster, Howard

AU - Connolly, Roisin

AU - Weise, Amy

AU - LoRusso, Patricia M.

AU - Salaria, Safia N.

AU - El-Rifai, Wael

AU - Berlin, Jordan D.

PY - 2018/12/1

Y1 - 2018/12/1

N2 - The authors would like to note that the investigator affiliations have been corrected to reflect the actual affiliations of each author. The authors would also like to note an amendment to the first name of the second author. Nilo Azad was changed to reflect the full name of the author, which is Nilofer S. Azad as shown above. The original article has been corrected.

AB - The authors would like to note that the investigator affiliations have been corrected to reflect the actual affiliations of each author. The authors would also like to note an amendment to the first name of the second author. Nilo Azad was changed to reflect the full name of the author, which is Nilofer S. Azad as shown above. The original article has been corrected.

UR - http://www.scopus.com/inward/record.url?scp=85055485240&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85055485240&partnerID=8YFLogxK

U2 - 10.1007/s10637-018-0679-5

DO - 10.1007/s10637-018-0679-5

M3 - Comment/debate

C2 - 30334109

AN - SCOPUS:85055485240

VL - 36

JO - Investigational New Drugs

JF - Investigational New Drugs

SN - 0167-6997

IS - 6

ER -